LV11972B - Piridazīna atvasinājums, tā iegūšanas paņēmiens un farmaceitiskā kompozīcija - Google Patents

Piridazīna atvasinājums, tā iegūšanas paņēmiens un farmaceitiskā kompozīcija Download PDF

Info

Publication number
LV11972B
LV11972B LVP-97-165A LV970165A LV11972B LV 11972 B LV11972 B LV 11972B LV 970165 A LV970165 A LV 970165A LV 11972 B LV11972 B LV 11972B
Authority
LV
Latvia
Prior art keywords
methylpropyl
amino
diethylamino
phenyl
propylpyridazine
Prior art date
Application number
LVP-97-165A
Other languages
English (en)
Latvian (lv)
Other versions
LV11972A (lv
Inventor
Robert Boigegrain
Roger Brodin
Jean-Paul Kan
Dominique Olliero
Camille Georges Wermuth
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8915137A external-priority patent/FR2654727B1/fr
Application filed by Sanofi filed Critical Sanofi
Publication of LV11972A publication Critical patent/LV11972A/xx
Publication of LV11972B publication Critical patent/LV11972B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LVP-97-165A 1989-11-17 1997-09-10 Piridazīna atvasinājums, tā iegūšanas paņēmiens un farmaceitiskā kompozīcija LV11972B (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8915137A FR2654727B1 (fr) 1989-11-17 1989-11-17 Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR909007533A FR2663326B2 (fr) 1989-11-17 1990-06-15 Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.

Publications (2)

Publication Number Publication Date
LV11972A LV11972A (lv) 1998-02-20
LV11972B true LV11972B (lv) 1998-04-20

Family

ID=26227673

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-97-165A LV11972B (lv) 1989-11-17 1997-09-10 Piridazīna atvasinājums, tā iegūšanas paņēmiens un farmaceitiskā kompozīcija

Country Status (21)

Country Link
EP (1) EP0429344B1 (ja)
JP (1) JPH03170465A (ja)
KR (1) KR0164599B1 (ja)
AR (1) AR247557A1 (ja)
AT (1) ATE143010T1 (ja)
AU (1) AU639043B2 (ja)
CA (1) CA2030133A1 (ja)
DE (1) DE69028602T2 (ja)
DK (1) DK0429344T3 (ja)
ES (1) ES2094146T3 (ja)
FI (1) FI101881B (ja)
FR (1) FR2663326B2 (ja)
GR (1) GR3021933T3 (ja)
HK (1) HK1000597A1 (ja)
HU (2) HU207852B (ja)
IE (1) IE75697B1 (ja)
IL (1) IL96384A (ja)
LV (1) LV11972B (ja)
NO (1) NO178967C (ja)
NZ (1) NZ236107A (ja)
PT (1) PT95902B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665442B1 (fr) * 1990-07-31 1992-12-04 Sanofi Sa Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
CA2237273C (en) * 1996-01-15 2009-01-13 Janssen Pharmaceutica N.V. Angiogenesis inhibiting pyridazinamines
HUP0101099A3 (en) * 1997-12-19 2002-09-30 Amgen Inc Thousand Oaks Substituted pyridine and pyridazine compounds and their pharmaceutical use
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
WO2002076391A2 (en) 2001-03-23 2002-10-03 Advanced Bionutrition Microbial feeds for aquaculture and agriculture
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
DE602006020330D1 (de) 2005-12-07 2011-04-07 Sumitomo Chemical Co Pyridazinverbindung und deren verwendung
FR2904314A1 (fr) * 2006-07-26 2008-02-01 Centre Nat Rech Scient Composes pyridaziniques et pyrroliques lineaires, procedes d'obtention et applications
AR081626A1 (es) * 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR119731A1 (es) 2019-05-17 2022-01-05 Novartis Ag Inhibidores del inflamasoma nlrp3
WO2021193897A1 (ja) * 2020-03-27 2021-09-30 アステラス製薬株式会社 置換ピリダジン化合物
JP2024505735A (ja) * 2021-02-08 2024-02-07 メッドシャイン ディスカバリー インコーポレイテッド 置換されたピリダジンフェノール系誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
DE3629929A1 (de) * 1986-09-03 1988-03-10 Thomae Gmbh Dr K Neue sulfonamido-aethylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
FR2642648B1 (fr) * 1989-02-07 1991-06-21 Sanofi Sa Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique
PT93060B (pt) * 1989-02-07 1995-12-29 Sanofi Sa Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem

Also Published As

Publication number Publication date
NO178967C (no) 1996-07-10
ES2094146T3 (es) 1997-01-16
FI905663A0 (fi) 1990-11-15
FI101881B1 (fi) 1998-09-15
KR0164599B1 (ko) 1999-01-15
PT95902A (pt) 1991-09-13
FR2663326A2 (fr) 1991-12-20
DE69028602T2 (de) 1997-04-03
DK0429344T3 (ja) 1997-03-03
EP0429344B1 (fr) 1996-09-18
AU6667290A (en) 1991-05-23
NZ236107A (en) 1992-10-28
IL96384A (en) 1995-10-31
JPH03170465A (ja) 1991-07-24
LV11972A (lv) 1998-02-20
HU211351A9 (en) 1995-11-28
HUT56078A (en) 1991-07-29
NO904984L (no) 1991-05-21
NO904984D0 (no) 1990-11-16
ATE143010T1 (de) 1996-10-15
CA2030133A1 (en) 1991-05-18
HU907178D0 (en) 1991-05-28
DE69028602D1 (de) 1996-10-24
GR3021933T3 (en) 1997-03-31
IE904145A1 (en) 1991-05-22
FR2663326B2 (fr) 1992-10-16
PT95902B (pt) 1998-01-30
FI101881B (fi) 1998-09-15
FI905663A (fi) 1991-05-18
AR247557A1 (es) 1995-01-31
HK1000597A1 (en) 1998-04-09
IE75697B1 (en) 1997-09-10
EP0429344A1 (fr) 1991-05-29
HU207852B (en) 1993-06-28
AU639043B2 (en) 1993-07-15
CA2030133C (ja) 1991-05-18
IL96384A0 (en) 1991-08-16
KR910009672A (ko) 1991-06-28
NO178967B (no) 1996-04-01

Similar Documents

Publication Publication Date Title
LV11972B (lv) Piridazīna atvasinājums, tā iegūšanas paņēmiens un farmaceitiskā kompozīcija
EP0082088B1 (fr) Nouveaux dérivés d&#39;aminoacides, et leur application thérapeutique
EP0373998B1 (fr) Ethers d&#39;oxime de propénone, procédé pour leur préparation et compositions pharmaceutiques les contenant
EP0477049A1 (fr) Dérivés d&#39;amido-3 pyrazole, procédé pour leur préparation et compositions pharmaceutiques les contenant
FR2679903A1 (fr) Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.
EP0432040A1 (fr) Dérivés hétérocycliques d&#39;acylaminothiazoles, leur préparation et compositions pharmaceutiques en contenant
EP0465323A1 (fr) Dérivés de pyrimidine antagonistes des récepteurs à l&#39;angiotensine II, leurs procédés de préparation et compositions pharmaceutiques les contenant
EP0231139B1 (fr) Nouveaux dérivés de dihydrobenzofuranne - et de chromane -carboxamides, leurs procédés de préparation et leur utilisation comme neuroleptiques
EP0073161B1 (fr) Nouveaux dérivés de la pyrazine actifs sur le système nerveux central
EP0001193B1 (fr) Amino-acides cycliques, leurs procédés d&#39;obtention et compositions pharmaceutiques les contenant
EP0382634A1 (fr) Nouveaux dérivés de la pyridazine, procédé de préparation et compositions pharmaceutiques en contenant
FR2628105A1 (fr) Derives d&#39;acylphenols
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
EP0566446A1 (fr) Dérivés d&#39;indane-1, 3-dione et d&#39;indane-1,2,3-trione, leurs procédés de préparation et leur application en thérapeutique
WO1998007681A1 (fr) Compositions pharmaceutiques contenant des acides 4-oxo-butanoiques
CH630606A5 (en) Phenylamidine derivatives useful especially in therapeutics
FR2645743A1 (fr) Compositions therapeutiques a base de derives di-substitues des n,n(prime)-ditrimethoxybenzoyle piperazines
CH675245A5 (ja)
FR2556721A1 (fr) Nouveaux derives de o-mercaptopropanamide d&#39;o amino-acides, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
EP0015171B1 (fr) Dérivés condensés de pyrrolidine ou de pipéridine, leur procédé de préparation et composition les contenant
CH633541A5 (en) Pharmacologically active substituted 1,2,4-triazines and medicaments containing these triazines
EP0294258A1 (fr) Dérivés d&#39;hydrazine, procédé d&#39;obtention et compositions pharmaceutiques les contenant
EP0382635B1 (fr) Utilisation de dérivés d&#39;alkyl-5 pyridazine comme médicaments actifs sur le système cholinergique
EP0534856B1 (fr) Ethers d&#39;oximes de thiénocyclopentanones, leur préparation et compositions pharmaceutiques les contenant
CH658786A5 (fr) Medicaments qui contiennent d&#39;alpha-(n-pyrrolyl)-acides ou de leurs sels ou esters.